Cytori Therapeutics, Inc. (CYTX) Reports In-Line Q1 Loss of 16c/Share

May 9, 2012 4:41 PM EDT Send to a Friend
Get Alerts CYTX Hot Sheet
Trade CYTX Now!
Join SI Premium – FREE
Cytori Therapeutics, Inc. (NASDAQ: CYTX) reported Q1 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $1.48 million, versus $1.36 million reported last year.

For earnings history and earnings-related data on Cytori Therapeutics, Inc. (CYTX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment